The Pediatric Cancer Research Center of the TTUHSC School of Medicine (http://cancer.TTUHSC.edu) is recruiting for a physician-scientist to an Assistant Professor level, tenure-track position in the field of pediatric cancer developmental therapeutics. The new faculty member will be supported by and be a member of the Texas Regional Excellence in Cancer (TREC) Developmental Therapeutics Center at TTUHSC funded by the Cancer Prevention & Research Institute of Texas (CPRIT). TREC faculty carry out translational and clinical research in cancer drug development and are funded by grants from CPRIT, the National Cancer Institute, and foundations. TREC faculty are supported by core resources for pharmacology, cancer animal models, a robust cancer biobank, and an early-phase clinical trial consortium (www.SPONC.org). The Children’s Oncology Group Childhood Cancer Repository (www.COGcell.org) located at TTUHSC provides patient-derived cell lines and xenografts to investigators in 30 countries. COG resource labs for assessing telomere maintenance mechanisms and antibody binding to neuroblastoma patient samples are also located at TTUHSC as is the CPRIT-funded West Texas Pharmacology Core laboratory. Examples of publications from TREC faculty: PMID: 31484706; PMID: 32291317; PMID: 32409685; PMID: 34408079.
Investigators working in all areas of cancer developmental therapeutics, including small molecule development, immunotherapy, and biomarker development are encouraged to apply. Rank and salary are dependent upon qualifications and experience. Clinical service time will be strictly limited, providing ample time for research. The primary appointment will in the Department of Pediatrics in the School of Medicine with a concurrent appointment in the Graduate School of Biomedical Sciences to enable the recruiting of excellent graduate students from the Biomedical Sciences and Biotechnology graduate programs. Salary and start-up support are nationally competitive.
Major/Essential Functions Commitment to sustained funded-translational research in childhood cancer. Translational and clinical research in cancer drug development. Limited clinical service time.
Required Qualifications: Medical Degree ABMS Board Eligible or Board Certified in Pediatric Oncology
Preferred Qualifications:
PhD Current research efforts in cancer developmental therapeutics including small molecule development, immunotherapy and biomarker development.
EEO Statement:
All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, national origin, age, disability, genetic information or status as a protected veteran.
Jeanne Clery Act The Jeanne Clery Disclosure of Campus Security Policy and Campus Crime Statistics Act is a federal statute requiring colleges and universities participating in federal financial aid programs to maintain and disclose campus crime statistics and security information. By October 1 of each year, institutions must publish and distribute their Annual Campus Security Policy & Crime Statistics Report (ASR) to current and prospective students and employees. To view this report, visit the TTUHSC Clery Act website at https://www.ttuhsc.edu/compliance/clery-report.aspx.
